RNA-Loaded Dendritic Cell Cancer Vaccine

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Renal Cell Carcinoma
Interventions
BIOLOGICAL

MB-002

Dendritic Cell Immunotherapy

Trial Locations (5)

14263

Roswell Park Cancer Institute, Buffalo

27599

University of North Carolina at Chapel Hill, Chapel Hill

92868

University of California - Irvine, Orange

Unknown

Princess Margaret Hospital, Toronto

Jewish General Hospital, Montreal

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Argos Therapeutics

INDUSTRY

NCT00087984 - RNA-Loaded Dendritic Cell Cancer Vaccine | Biotech Hunter | Biotech Hunter